Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis

Moraes et al., NCT04384458, NCT04384458, Apr 2021

4th treatment shown to reduce risk in August 2020, now with p < 0.00000000001 from 106 studies, recognized in 24 countries.

Lower risk for mortality, ventilation, ICU, hospitalization, recovery, cases, and viral clearance.

No treatment is 100% effective. Protocols combine treatments.

6,300+ studies for 210+ treatments. c19early.org

Meta Analysis

Estimated 400 participant ivermectin vs. HCQ prophylaxis RCT with results not reported over 4 years after estimated completion.

3 ivermectin RCTs have results missing long after expected1-3
The trials report an estimated total of 912 patients.

Important missing comments or errors? Let us know.

Study covers ivermectin and HCQ.

1. PREVENT-COVID, Prophylaxis of COVID-19 Disease With Ivermectin in COVID-19 Contact Persons, clinicaltrials.gov/study/NCT05060666clinicaltrials.gov.

2. Moraes et al., Comparative Study of Hydroxychloroquine and Ivermectin in COVID-19 Prophylaxis, NCT04384458, clinicaltrials.gov/study/NCT04384458clinicaltrials.gov.

3. Kamal et al., Ivermectin In Treatment of COVID 19 Patients, NCT04425707, clinicaltrials.gov/study/NCT04425707clinicaltrials.gov.

Moraes et al., 30 Apr 2021, Randomized Controlled Trial, this trial compares with another treatment - results may be better when compared to placebo, trial NCT04384458 (history).